Berg has signed a cooperative research and development agreement with the US Department of Defense, to advance prostate cancer research.
The Uniformed Services University of the Health Sciences' (USU) Center for Prostate Disease Research (CPDR) and The Henry M. Jackson Foundation for the Advancement of Military Medicine (HJF) also form part of the partnership.
Open data-sharing collaboration with Uniformed Services University and Henry M. Jackson Foundation for the Advancement of Military Medicine will offer new model for scientific discovery.
Berg will follow a data-driven approach and the CPDR will identify biomarkers and better therapies to drive molecular intelligence of prostate cancer.
Berg co-founder, president and CTO Niven Narain said the CPDR has embarked on one of the most comprehensive prostate cancer research programs in the world.
"This collaboration is an ideal marriage of the CPDR's extensive prostate cancer expertise and Berg's unparallelled ability to drive a deeper level of biological understanding," Narain added.
"Together, we have the potential to change the meaning of a prostate cancer diagnosis, and hopefully prognosis, while exemplifying how industry and government can work together to enact real change in public health."
The collaboration will make use of Berg's expertise in computational biology and Interrogative Biology platform, which integrates molecular data directly from a patient with clinical and demographic information, to analyse the prostate cancer data supplied by CPDR.
